BACH1 Ser919Pro variant and breast cancer risk
2006

BACH1 Ser919Pro Variant and Breast Cancer Risk

Sample size: 888 publication Evidence: moderate

Author Information

Author(s): Vahteristo Pia, Yliannala Kristiina, Tamminen Anitta, Eerola Hannaleena, Blomqvist Carl, Nevanlinna Heli

Primary Institution: Helsinki University Central Hospital

Hypothesis

This study aimed to evaluate whether there are BACH1 genetic variants that contribute to breast cancer risk in Finland.

Conclusion

The BACH1 Ser919 variant is not associated with an increased risk of breast cancer in the Finnish population.

Supporting Evidence

  • Six BACH1 germ line alterations were observed, but none associated with breast cancer.
  • Individuals with the BACH1 Ser919-allele did not show increased breast cancer risk.
  • The study included a large sample size of breast cancer patients and healthy controls.

Takeaway

The study looked at a gene called BACH1 to see if it makes people more likely to get breast cancer, but it found that it doesn't.

Methodology

The BACH1 gene was screened for germ line alterations among probands from 43 Finnish BRCA1/2 negative breast cancer families and evaluated in a large series of 888 unselected breast cancer patients and 736 healthy controls.

Limitations

The study may not account for all genetic factors influencing breast cancer risk.

Participant Demographics

Participants included 888 breast cancer patients and 736 healthy controls from Finland.

Statistical Information

P-Value

0.427

Confidence Interval

95% CI 0.70–1.16

Statistical Significance

p = 0.427

Digital Object Identifier (DOI)

10.1186/1471-2407-6-19

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication